Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer distinguished by the lack of expression of ER (estrogen receptors), PR (progesterone receptors), and HER2 (human epidermal growth factor receptor 2). Here, ESR1 is linked to breast carcinoma.